Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (<em>STAT1</em>) or <em>STAT3</em> mutations

Authors
Publication date
1 January 2018
Publisher
Mosby Inc.

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Newcastle University E-Prints

    redirect
    oaioai:eprints.ncl.ac.uk:251393
    Last time updated on 30/05/2021